Tokyo, Japan

Akiko Shiina

This inventor holds 1 USPTO granted patent. Top assignee: Arqule, Inc.. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Akiko Shiina. Retrieved from https://idiyas.com/inventor/akiko-shiina

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 13.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Akiko Shiina: Innovator in Pharmaceutical Compounds

Introduction

Akiko Shiina is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds for treating cell proliferative disorders.

Latest Patents

Akiko Shiina holds 1 patent for her invention titled "Substituted benzo[f]imidazo[1,2-d]pyrido[2,3-b][1,4]diazepine compounds." This invention relates to the synthesis of these compounds and their application in pharmaceutical compositions aimed at treating conditions such as cancer. The methods she developed are crucial for advancing therapeutic options for patients in need.

Career Highlights

Throughout her career, Akiko has demonstrated a strong commitment to research and innovation. Her work at Arqule, Inc. has positioned her as a key player in the pharmaceutical industry. She has focused on creating effective treatments that can significantly impact patient outcomes.

Collaborations

Akiko has collaborated with notable colleagues, including Mark Anthony Ashwell and Sudharshan Eathiraj. These partnerships have enhanced her research efforts and contributed to the success of her projects.

Conclusion

Akiko Shiina's contributions to the field of pharmaceuticals through her innovative compounds and collaborative efforts highlight her importance as an inventor. Her work continues to pave the way for advancements in cancer treatment and other cell proliferative disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…